Back to today’s briefing

Story perspectives

Outrage Over Hims & Hers Ad Ignites FDA Investigation

2/7/2025

46 9

Summary

Story summary

Hims & Hers sparked outrage with a Super Bowl ad for compounded weight-loss drugs, leading Senators Durbin and Marshall to call for an FDA investigation over misleading claims. The ad's absence of safety warnings and crucial side effects has ignited fears about consumer safety in pharmaceutical marketing, yet Hims' stock soared amidst the controversy.

History

Historical Context

Hims & Hers' controversial Super Bowl ad for compounded weight-loss drugs echoes past pharmaceutical marketing scandals. The 1997 FDA Modernization Act loosened advertising regulations, leading to misleading promotions. Similar outrage followed the OxyContin crisis, where deceptive marketing fueled an opioid epidemic, highlighting ongoing consumer safety concerns in drug advertising.

1 of 2

Story summary

Hims & Hers sparked outrage with a Super Bowl ad for compounded weight-loss drugs, leading Senators Durbin and Marshall to call for an FDA investigation over misleading claims. The ad's absence of safety warnings and crucial side effects has ignited fears about consumer safety in pharmaceutical marketing, yet Hims' stock soared amidst the controversy.

1 / 2